LobbyingA.P. Goldshield lobbying by quarter
A.P. Goldshield's latest lobbying report covers Q1 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Chemicals/Chemical Industry.
A.P. Goldshield
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $10K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$38.3K · 7 reports
- Chemicals$18.3K · 5 reports
- Environment and Superfund$8,333 · 3 reports
- Agriculture$5,000 · 2 reports
- Immigration$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)6 reports
- Commerce, Dept of (DOC)5 reports
- Environmental Protection Agency (EPA)5 reports
- HOUSE OF REPRESENTATIVES5 reports
- SENATE4 reports
- Health & Human Services, Dept of (HHS)2 reports
- Agriculture, Dept of (USDA)1 reports
- Centers For Disease Control & Prevention (CDC)1 reports
- Smithsonian Institution1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Rem Strategies | $70K | 10 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ROBERT E. MILLS | lobbyist, President REM Strategies LLC | Q2 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/04/17for Q1 2025 | Rem Strategies | Under $5,000 |
| 25/01/20for Q4 2024 | Rem Strategies | Under $5,000 |
| 24/10/21for Q3 2024 | Rem Strategies | Under $5,000 |
| 24/07/16for Q2 2024 | Rem Strategies | $10K |
| 24/04/16for Q1 2024 | Rem Strategies | $10K |
| 24/01/18for Q4 2023 | Rem Strategies | $10K |
| 23/10/19for Q3 2023 | Rem Strategies | $10K |
| 23/07/19for Q2 2023 | Rem Strategies | $10K |
| 23/04/17for Q1 2023 | Rem Strategies | $10K |
| 23/01/19for Q4 2022 | Rem Strategies | $10K |